Alkem Laboratories Limited (ALKEM.NS)
INR 5510.55
(0.32%)
INR 5510.55
(0.32%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 52.29 Billion INR | -21.86% |
| 2022 | 66.92 Billion INR | 7.44% |
| 2021 | 62.28 Billion INR | 21.13% |
| 2020 | 51.42 Billion INR | 8.51% |
| 2019 | 47.38 Billion INR | 13.16% |
| 2018 | 41.87 Billion INR | 13.31% |
| 2017 | 36.95 Billion INR | 12.36% |
| 2016 | 32.89 Billion INR | 13.02% |
| 2015 | 29.1 Billion INR | 48.37% |
| 2014 | 19.61 Billion INR | 28.16% |
| 2013 | 15.3 Billion INR | 10.84% |
| 2012 | 13.8 Billion INR | 18.32% |
| 2011 | 11.66 Billion INR | 26.88% |
| 2010 | 9.19 Billion INR | 25.03% |
| 2009 | 7.35 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 12.73 Billion INR | 2.74% |
| 2023 Q1 | 17.69 Billion INR | 7.41% |
| 2023 Q2 | 21.13 Billion INR | 19.44% |
| 2023 Q4 | 12.39 Billion INR | -38.63% |
| 2023 FY | 52.29 Billion INR | -21.86% |
| 2023 Q3 | 20.19 Billion INR | -4.44% |
| 2022 Q2 | 17.72 Billion INR | 19.68% |
| 2022 Q3 | 17.91 Billion INR | 1.1% |
| 2022 Q1 | 14.8 Billion INR | 20.66% |
| 2022 FY | 66.92 Billion INR | 7.44% |
| 2022 Q4 | 16.47 Billion INR | -8.09% |
| 2021 Q3 | 16.22 Billion INR | -6.9% |
| 2021 FY | 62.28 Billion INR | 21.13% |
| 2021 Q4 | 12.27 Billion INR | -24.35% |
| 2021 Q2 | 17.42 Billion INR | 6.47% |
| 2021 Q1 | 16.36 Billion INR | 59.71% |
| 2020 Q1 | 12.69 Billion INR | 42.05% |
| 2020 FY | 51.42 Billion INR | 8.51% |
| 2020 Q2 | 14.28 Billion INR | 12.54% |
| 2020 Q4 | 10.24 Billion INR | -28.36% |
| 2020 Q3 | 14.3 Billion INR | 0.11% |
| 2019 Q3 | 13.47 Billion INR | -0.91% |
| 2019 FY | 47.38 Billion INR | 13.16% |
| 2019 Q4 | 8.93 Billion INR | -33.67% |
| 2019 Q1 | 11.37 Billion INR | 21.36% |
| 2019 Q2 | 13.59 Billion INR | 19.52% |
| 2018 FY | 41.87 Billion INR | 13.31% |
| 2018 Q4 | 9.37 Billion INR | -14.94% |
| 2018 Q3 | 11.02 Billion INR | -4.58% |
| 2018 Q2 | 11.54 Billion INR | 15.11% |
| 2018 Q1 | 10.03 Billion INR | 11.83% |
| 2017 Q1 | 7.32 Billion INR | -7.31% |
| 2017 FY | 36.95 Billion INR | 12.36% |
| 2017 Q4 | 8.97 Billion INR | -19.47% |
| 2017 Q3 | 11.14 Billion INR | -3.7% |
| 2017 Q2 | 11.56 Billion INR | 57.86% |
| 2016 FY | 32.89 Billion INR | 13.02% |
| 2016 Q2 | 9.73 Billion INR | 13.15% |
| 2016 Q1 | 8.6 Billion INR | 19.85% |
| 2016 Q4 | 7.9 Billion INR | -14.23% |
| 2016 Q3 | 9.21 Billion INR | -5.33% |
| 2015 Q4 | 7.17 Billion INR | -2.59% |
| 2015 Q1 | 7.21 Billion INR | 46.53% |
| 2015 FY | 29.1 Billion INR | 48.37% |
| 2015 Q3 | 7.37 Billion INR | -9.29% |
| 2015 Q2 | 8.12 Billion INR | 12.61% |
| 2014 Q4 | 4.92 Billion INR | -11.56% |
| 2014 Q3 | 5.56 Billion INR | 21.45% |
| 2014 Q2 | 4.58 Billion INR | 0.0% |
| 2014 Q1 | 4.58 Billion INR | 0.0% |
| 2014 FY | 19.61 Billion INR | 28.16% |
| 2013 FY | 15.3 Billion INR | 10.84% |
| 2012 FY | 13.8 Billion INR | 18.32% |
| 2011 FY | 11.66 Billion INR | 26.88% |
| 2010 FY | 9.19 Billion INR | 25.03% |
| 2009 FY | 7.35 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sigachi Industries Limited | 2 Billion INR | -2511.864% |
| Ind-Swift Limited | 2.17 Billion INR | -2307.188% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -3453.247% |
| Sakar Healthcare Limited | 699.58 Million INR | -7375.418% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 52.259% |
| Innova Captab Limited | 3.46 Billion INR | -1409.534% |
| Divi's Laboratories Limited | 32.44 Billion INR | -61.211% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -740.421% |
| Morepen Laboratories Limited | 6.16 Billion INR | -748.799% |
| Mankind Pharma Limited | 42.19 Billion INR | -23.935% |
| Sequent Scientific Limited | 2.97 Billion INR | -1655.678% |
| Wanbury Limited | 1.73 Billion INR | -2921.819% |
| Laurus Labs Limited | 15.44 Billion INR | -238.52% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -984.258% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -320.63% |
| Alembic Limited | 1 Billion INR | -5129.13% |
| Hikal Limited | 5.95 Billion INR | -777.759% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | -95.278% |
| Neuland Laboratories Limited | 8.24 Billion INR | -534.068% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | -242.73% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 24.58% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -1008.196% |
| Themis Medicare Limited | 2.42 Billion INR | -2061.023% |
| RPG Life Sciences Limited | 2.48 Billion INR | -2006.198% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 58.233% |
| Lupin Limited | 125.09 Billion INR | 58.194% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -2397.42% |
| Wockhardt Limited | 7.72 Billion INR | -577.421% |
| Vaishali Pharma Limited | 90.32 Million INR | -57799.87% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -796.823% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -7913.745% |
| Jubilant Pharmova Limited | 19.64 Billion INR | -166.237% |
| FDC Limited | 6.58 Billion INR | -694.036% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 68.035% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -8328.499% |
| Eris Lifesciences Limited | 10.42 Billion INR | -401.563% |
| Venus Remedies Limited | 2.18 Billion INR | -2296.099% |
| ZIM Laboratories Limited | 1.26 Billion INR | -4024.97% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -1315.176% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -9783.452% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | -468.043% |
| Shilpa Medicare Limited | 3.56 Billion INR | -1368.232% |
| Albert David Limited | 1.4 Billion INR | -3614.039% |
| Ajanta Pharma Limited | 21.06 Billion INR | -148.276% |
| Hester Biosciences Limited | 1.27 Billion INR | -4006.065% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -1168.334% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 3258.216% |
| Gufic Biosciences Limited | 4.07 Billion INR | -1183.759% |
| Windlas Biotech Limited | 1.33 Billion INR | -3806.252% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -804.572% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -46168.568% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -7466.179% |
| Granules India Limited | 16.79 Billion INR | -211.304% |
| Aarti Drugs Limited | 8.31 Billion INR | -528.856% |
| Bal Pharma Limited | 770.19 Million INR | -6690.086% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 79.768% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -2671.628% |
| Medicamen Biotech Limited | 495.49 Million INR | -10454.476% |
| Unichem Laboratories Limited | 4.86 Billion INR | -974.977% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -11466.195% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -416774.452% |
| Valiant Laboratories Limited | 138.02 Million INR | -37788.342% |
| Orchid Pharma Limited | 2.32 Billion INR | -2153.882% |
| Medico Remedies Limited | 262.14 Million INR | -19849.684% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -1165.283% |
| Ipca Laboratories Limited | 48.58 Billion INR | -7.642% |
| Brooks Laboratories Limited | 65.62 Million INR | -79596.586% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -9247.028% |
| Piramal Enterprises Limited | 8.04 Billion INR | -550.192% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | -11.848% |
| NATCO Pharma Limited | 25.73 Billion INR | -103.205% |
| Suven Life Sciences Limited | -200.79 Million INR | 26144.662% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 48190.43% |
| Strides Pharma Science Limited | 14.38 Billion INR | -263.473% |
| Indoco Remedies Limited | 8.04 Billion INR | -550.216% |
| Alpa Laboratories Limited | 188.89 Million INR | -27585.698% |
| Lasa Supergenerics Limited | 121.02 Million INR | -43109.866% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -13272.909% |